GlucoSentient Overview

  • Founded
  • 2011

Founded
  • Status
  • Private

  • Employees
  • 3

Employees
  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

GlucoSentient General Information

Description

Manufacturer of blood glucose meter designed to come up with therapeutic drug and disease monitoring. The company's glucose meters assists to quantitatively and conveniently detect non-glucose levels anytime, anywhere, enabling health care providers to take immediate medical decisions without any delay.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Monitoring Equipment
Primary Office
  • 2100 South Oak Street
  • Suite 101
  • Champaign, IL 61820
  • United States
+1 (217) 000-0000

GlucoSentient Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GlucoSentient Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private 01-Mar-2021 0000 Completed Generating Revenue
6. Grant 30-Jun-2019 00.000 0000 Completed Generating Revenue
5. Grant 01-Jan-2018 00.000 0000 Completed Generating Revenue
4. Early Stage VC 12-Oct-2012 00000 0000 Completed Generating Revenue
3. Grant 01-Jun-2012 00000 Completed Generating Revenue
2. Grant 11-Apr-2012 $10K Completed Generating Revenue
1. Accelerator/Incubator 14-Dec-2011 Completed Generating Revenue
To view GlucoSentient’s complete valuation and funding history, request access »

GlucoSentient Executive Team (5)

Name Title Board Seat Contact Info
Tian Lan Ph.D Co-Founder & Chief Technology Officer
Yi Lu Co-Founder & Scientific Advisor
Steven Mayer MD Chief Medical Officer & Board Member
You’re viewing 3 of 5 executive team members. Get the full list »

GlucoSentient Board Members (2)

Name Representing Role Since
Steven Mayer MD GlucoSentient Chief Medical Officer & Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

GlucoSentient Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GlucoSentient Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view GlucoSentient’s complete investors history, request access »